Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-05 5:26 pm Unchanged |
2021-04-05 | 13D | Agios Pharmaceuticals, Inc. AGIO |
BRISTOL MYERS SQUIBB CO BMY |
0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-04-05 5:26 pm Purchase |
2019-11-20 | 13G | Jounce Therapeutics, Inc. JNCE |
BRISTOL MYERS SQUIBB CO BMY |
3,456,463 7.600% |
3,456,463 (New Position) |
Filing History |
| 2021-04-05 5:25 pm Purchase |
2021-03-25 | 13G | Ikena Oncology, Inc. IKNA |
BRISTOL MYERS SQUIBB CO BMY |
2,133,142 5.900% |
2,133,142 (New Position) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Bristol-Myers Squibb Company BMY |
The Vanguard Group | 199,340,458 8.820% |
4,480,304 (+2.30%) |
Filing History |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Bristol-Myers Squibb Company BMY |
BLACKROCK INC BLK |
172,464,804 7.600% |
1,121,358 (+0.65%) |
Filing History |
| 2020-07-16 5:01 pm Purchase |
2020-07-01 | 13D | Acceleron Pharma Inc. XLRN |
BRISTOL MYERS SQUIBB CO BMY |
7,008,510 12.000% |
7,008,510 (New Position) |
Filing History |